1-8 of 8
Satoshi Inoue
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Inhibition of PSF Activity Overcomes Resistance to Treatment in Cancers Harboring Mutant p53

Ken-ichi Takayama, Tomohiro Sato, Teruki Honma, Minoru Yoshida, Satoshi Inoue
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther OF1–OF14.
https://doi.org/10.1158/1535-7163.MCT-24-0418
Published: 18 December 2024
View article titled, Inhibition of PSF Activity Overcomes Resistance to Treatment in Cancers Harboring Mutant p53
Open the PDF for Inhibition of PSF Activity Overcomes Resistance to Treatment in Cancers Harboring Mutant p53 in another window
Includes: Supplementary data
Journal Articles

Abstract B004: Ovarian cancer long intergenic noncoding RNA 1 is a potential therapeutic target in advanced ovarian cancer by promoting glycolytic pathway and hypoxic response

Kuniko Horie, Wataru Sato, Kazuhiro Ikeda, Satoshi Inoue
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2024) 23 (11_Supplement): B004.
https://doi.org/10.1158/1538-8514.RNADRIVERS24-B004
Published: 14 November 2024
View article titled, Abstract B004: <em>Ovarian cancer long intergenic noncoding RNA 1</em> is a potential therapeutic target in advanced ovarian cancer by promoting glycolytic pathway and hypoxic response
Journal Articles

ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs

Shuntaro Tsukamoto, Naoko Hata Sugi, Kyoko Nishibata, Youya Nakazawa, Daisuke Ito, Sayo Fukushima, Takayuki Nakagawa, Kenji Ichikawa, Yu Kato, Dai Kakiuchi, Aya Goto, Machiko Itoh-Yagi, Tomoki Aota, Satoshi Inoue, Yoshinobu Yamane, Norio Murai, Hiroshi Azuma, Satoshi Nagao, Ken Sasai, Tsuyoshi Akagi, Toshio Imai, Junji Matsui, Tomohiro Matsushima
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2023) 22 (1): 12–24.
https://doi.org/10.1158/1535-7163.MCT-21-0879
Published: 03 January 2023
View article titled, ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs
Open the PDF for ER-851, a Novel Selective Inhibitor of AXL, Overcomes Resistance to Antimitotic Drugs in another window
Includes: Supplementary data
Journal Articles

Androgen Receptor Signaling Reduces the Efficacy of Bacillus Calmette-Guérin Therapy for Bladder Cancer via Modulating Rab27b-Induced Exocytosis

Taichi Mizushima, Guiyang Jiang, Takashi Kawahara, Peng Li, Bin Han, Satoshi Inoue, Hiroki Ide, Ikuma Kato, Mehrsa Jalalizadeh, Etsuko Miyagi, Mitsunori Fukuda, Leonardo O. Reis, Hiroshi Miyamoto
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2020) 19 (9): 1930–1942.
https://doi.org/10.1158/1535-7163.MCT-20-0050
Published: 02 September 2020
View article titled, Androgen Receptor Signaling Reduces the Efficacy of Bacillus Calmette-Guérin Therapy for Bladder Cancer via Modulating Rab27b-Induced Exocytosis
Open the PDF for Androgen Receptor Signaling Reduces the Efficacy of Bacillus Calmette-Guérin Therapy for Bladder Cancer via Modulating Rab27b-Induced Exocytosis in another window
Includes: Supplementary data
Journal Articles

Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer

Hiroki Ide, Satoshi Inoue, Taichi Mizushima, Guiyang Jiang, Kuang-Hsiang Chuang, Mototsugu Oya, Hiroshi Miyamoto
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (7): 1566–1574.
https://doi.org/10.1158/1535-7163.MCT-17-1061
Published: 01 July 2018
View article titled, Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer
Open the PDF for Androgen Receptor Signaling Reduces Radiosensitivity in Bladder Cancer in another window
Includes: Supplementary data
Journal Articles

Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling

Satoshi Inoue, Hiroki Ide, Taichi Mizushima, Guiyang Jiang, George J. Netto, Momokazu Gotoh, Hiroshi Miyamoto
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2018) 17 (6): 1303–1314.
https://doi.org/10.1158/1535-7163.MCT-17-0786
Published: 31 May 2018
View article titled, Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling
Open the PDF for Nuclear Factor-κB Promotes Urothelial Tumorigenesis and Cancer Progression via Cooperation with Androgen Receptor Signaling in another window
Includes: Supplementary data
Journal Articles

Enhanced Fas-associated death domain recruitment by histone deacetylase inhibitors is critical for the sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis

Satoshi Inoue, Nick Harper, Renata Walewska, Martin J.S. Dyer, Gerald M. Cohen
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2009) 8 (11): 3088–3097.
https://doi.org/10.1158/1535-7163.MCT-09-0451
Published: 10 November 2009
View article titled, Enhanced Fas-associated death domain recruitment by histone deacetylase inhibitors is critical for the sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis
Open the PDF for Enhanced Fas-associated death domain recruitment by histone deacetylase inhibitors is critical for the sensitization of chronic lymphocytic leukemia cells to TRAIL-induced apoptosis in another window
Includes: Supplementary data
Journal Articles

Sulindac enhances adenoviral vector expressing mda-7/IL-24–mediated apoptosis in human lung cancer

Yasuhisa Oida, Began Gopalan, Ryo Miyahara, Satoshi Inoue, Cynthia D. Branch, Abner M. Mhashilkar, E. Lin, B. Nebiyou Bekele, Jack A. Roth, Sunil Chada, Rajagopal Ramesh
Journal: Molecular Cancer Therapeutics
Mol Cancer Ther (2005) 4 (2): 291–304.
https://doi.org/10.1158/1535-7163.291.4.2
Published: 15 February 2005
View article titled, Sulindac enhances adenoviral vector expressing <em>mda-7/IL-24</em>–mediated apoptosis in human lung cancer
Open the PDF for Sulindac enhances adenoviral vector expressing <em>mda-7/IL-24</em>–mediated apoptosis in human lung cancer in another window